1. Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger 
Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal Candolfi, PhD, Claudia Loardi, MD, Alain Mirza, MD, Julie Boulanger-Lothion, MD, Anne-Lorraine Bouquiaux-Stablo-Duncan, MD, Fabien Espitalier, MD, Michel Marchand, MD, Michel Aupart, MD 
The Annals of Thoracic Surgery 
Volume 100, Issue 3, Pages (September 2015)
DOI: /j.athoracsur
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Kaplan-Meier estimates of overall (red) and valve-related survival with (blue) and without early death (green).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Kaplan-Meier estimates of cumulative incidence of the following valve-related complications: thromboembolism (blue), bleeding events (maroon), and endocarditis (yellow).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Kaplan-Meier estimates of freedom from reoperation (blue), structural valve deterioration (SVD; red), and explant as a result of structural valve deterioration (green). The expected valve durability (median survival time without structural valve deterioration) was 17.6 years.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

5. Fig 4
Competing risk analysis—cumulative risk of valve explantation (green) and death (red). Event-free survival is shown in blue.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions